Imugene Ltd doses first combination patient in lung cancer clinical trial

Imugene Ltd (ASX:IMU, OTC:IUGNF) has dosed its first combination patient in the PD1-Vaxx and Immune Checkpoint Inhibitor lung cancer clinical trial. The...

Related Keywords

Australia ,United States ,Leslie Chong ,Imugene Ltd ,Immune Checkpoint Inhibitor ,